<DOC>
	<DOCNO>NCT02438631</DOCNO>
	<brief_summary>The investigator aim integrate outcome physiology-based pharmacokinetic ( PBPK ) model put generate data context medical condition require maternal fetal drug therapy ( e.g . HIV ) . These model validate available 'real-life ' maternal fetal PK data , data PANNA network . Ultimately , PBPK model drug therapy pregnancy provide powerful tool 1 . ) assist design rational dosing adjustment , 2 . ) prevent intervention-based research pregnant woman future , 3 . ) guide future development new molecular entity ( e.g . prevent heavy investment drug high predict fetal exposure potentially toxic effect utero ) .</brief_summary>
	<brief_title>Placental Passage Disposition Drugs : A Physiology-based Approach</brief_title>
	<detailed_description />
	<criteria>Female Age &gt; 18 Signed inform consent Retained placenta HIV infect Known hepatitis C infection Multiple pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>placenta</keyword>
	<keyword>placental passage</keyword>
</DOC>